Plain-English translation of NCT05981911 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Coronary Artery Disease research guide →This trial is testing how well the XIENCE Skypoint stent works in real-world practice for patients with coronary artery disease (clogged heart arteries). Researchers want to compare this newer stent to other similar stents that are already in use, tracking how safely and effectively it prevents future heart problems in everyday patients like you.
While this medication has been tested in controlled settings, doctors want to see how well it performs in real patients with different health conditions and backgrounds. This helps confirm that the treatment works as expected outside the laboratory.
You likely qualify if…
You likely don't qualify if…
If you join this study, you will receive the XIENCE Skypoint stent as part of your regular heart care, and then researchers will follow your progress over time. You'll attend scheduled clinic visits where doctors will monitor how well the stent is working and check for any side effects. The study is enrolling 2,000 patients to gather real-world information about how this treatment performs.
AI-generated summary from trial data · Jul 10, 2026 · Not medical advice
South Korea
Seung-Jung Park
Collaborators
CardioVascular Research Foundation, Korea
Enrollment target
~2,000 participants
Started
December 2023
Primary completion
June 2026
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
19 Years and older
Last updated on clinicaltrials.gov in January 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jung-hee Ham, Project manager
Seung-Jung Park
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.